Yamashita, Yusuke, Yoshikazu Hori, Hideki Kosako, Takehiro Oiwa, Kenji Warigaya, Toshiki Mushino, Shogo Murata, Masakazu Fujimoto, Akinori Nishikawa, Shin-ichi Murata, Takashi Sonoki, and Shinobu Tamura. “Brentuximab Vedotin for Refractory Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in Leukemic Phase With <em>RUNX3</em&gt; Overexpression”. Hematology Reports 12, no. 1 (May 15, 2020). Accessed September 22, 2020. https://www.pagepress.org/journals/index.php/hr/article/view/8368.